Evan T. Powers

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

Christine Bulawa, Stephen Connelly, Michael J. DeVit et al. · Proceedings of the National Academy of Sciences · 2012 · 742 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss

Maria Talantova, Sara Sanz‐Blasco, Xiaofei Zhang et al. · Proceedings of the National Academy of Sciences · 2013 · 589 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics

Per Hammarström, R. Luke Wiseman, Evan T. Powers et al. · Science · 2003 · 522 citations

Life Sciences, Biochemistry, Molecular Biology +17

Amyloid-β forms fibrils by nucleated conformational conversion of oligomers

Jiyong Lee, Elizabeth K. Culyba, Evan T. Powers et al. · Nature Chemical Biology · 2011 · 381 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity

Per Hammarström, Xin Jiang, Amy R. Hurshman et al. · Proceedings of the National Academy of Sciences · 2002 · 355 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17